Search your stocks

Share

Profile

GLAXOGlaxosmithkline Pharmaceuticals Ltd.

2745(-0.38%)

1W: -2.31%

1M: -2.59%

1Y: +38.72%

Financials

Charts

YoY Net Sales

Operating Margin

EPS Growth

Pros & Cons

POSITIVES

Revenue increased significantly in the latest quarter, reaching ₹1,010.77 Crore, marking a strong growth compared to previous quarters.
Net profit surged to ₹252.50 Crore in the last quarter, indicating improved profitability and operational efficiency.
Operating profit margin improved consistently, achieving 30.13% in the latest quarter, showcasing effective cost management.

NEGATIVES

Despite strong revenue growth, expenses also rose, particularly material costs, which could pressure future margins.
The profit before tax showed fluctuations, highlighting potential instability in earnings across the quarters.
Net profit dropped sharply to ₹45.72 Crore in Q3 2023, raising concerns about consistency in profitability.

Quarterly Results Data

Field	Trend	Sep 23	Dec 23	Mar 24	Jun 24	Sep 24	Dec 24	Mar 25	Jun 25
Revenue		956.99	805.26	929.80	814.65	1,010.77	949.42	974.37	805.17
Expenses		686.04	604.63	691.41	600.89	706.19	676.39	656.48	569.91
Operating Profit		270.95	200.63	238.39	213.76	304.58	273.03	317.89	235.26
Other Income		28.21	28.11	29.83	35.64	34.54	35.07	40.68	43.72
Interest		0.43	0.32	0.77	0.37	0.27	0.09	0.58	0.42
Depreciation		18.11	17.11	18.10	16.41	16.86	18.80	14.72	15.52
Profit Before Tax		299.16	65.43	270.62	249.40	343.81	308.10	358.57	278.98
Tax		81.65	19.71	76.14	67.07	91.31	78.22	95.70	73.97
Net Profit		217.51	45.72	194.48	182.33	252.50	229.88	262.87	205.01
Eps in Rs		12.84	2.70	11.48	10.76	14.91	13.57	15.52	12.10